(Q24248004)

3

0 references

Doug Coyle

4

Doug Coyle

0 references

George Wells

7

George A Wells

0 references

Marc C. Hochberg

5

Marc C Hochberg

0 references

Ann Cranney

2

Ann Cranney

0 references

author name string

Barbara BTB Blumenauer

Cochrane Database of Systematic Reviews

1

0 references

publication date

21 July 2003

0 references

published in

0 references

cites work

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004525

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004525

Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004525

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004525

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004525

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004525

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004525

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004525

Evidence-Based Rheumatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004525

ACR 20: clinical or statistical significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004525

7 January 2021

Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004525

7 January 2021

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004525

7 January 2021

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004525

7 January 2021